India Cancer Diagnostics Market: Industry Size and Growth Trends [2028] Analyzed by TechSci ResearchPosted by Kumar on May 28th, 2024 According to the TechSci Research report, “India Cancer Diagnostics Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028,” the India Cancer Diagnostics Market stood at USD 571.03 billion in 2022 and is anticipated to grow with a CAGR of 7.36% in the forecast period, 2024-2028. Awareness among individuals regarding cancer diagnostics has led to favorable market conditions for the India Cancer Diagnostics market. Several factors contribute to the growth of various cancer diagnostics products, including advancements in technology, government initiatives, and increased healthcare investments. Market Dynamics
Rising Incidence of Cancer In 2022, the projected number of new cancer cases in India was 1,461,427, with a crude incidence rate of 100.4 per 100,000 individuals. Approximately one in nine people in India is expected to face a cancer diagnosis during their lifetime. Notably, lung cancer ranked highest among males, while breast cancer held the top spot for females. Within childhood cancers (0-14 years), lymphoid leukemia emerged as the predominant site, accounting for 29.2% in boys and 24.2% in girls. Looking ahead, an estimated 12.8% increase in cancer incidence by 2025 is expected compared to 2020. Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Cancer Diagnostics Market.” - https://www.techsciresearch.com/report/india-cancer-diagnostics-market/18914.html Government Initiatives and Screening Programs Governments in developed countries and primary care doctors are recommending cancer screening tests for patients. The US Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer starting at 50 years of age to 75 years of age in the US to prevent disease incidence and ensure early-stage treatment. Canada has also implemented guidelines for biennial colorectal cancer screening for people aged 50 to 74 years. In India, the National Cancer Control Programme emphasizes early detection and treatment, leading to increased cancer diagnostics activities. Technological Advancements Technological advancements in cancer diagnostics, including genetic profiling, biomarker analysis, and imaging techniques, have significantly improved the accuracy and speed of cancer diagnosis. Telemedicine platforms have also enhanced accessibility to cancer diagnostic consultations, saving travel time and reducing waiting periods for appointments. Advanced diagnostic technologies, such as molecular tests and imaging, often provide quicker results compared to traditional methods, enabling prompt treatment planning. Recent Trends Precision Medicine Cancer diagnostics, including genetic profiling and biomarker analysis, enable precision medicine approaches. These techniques help oncologists tailor treatment plans to the specific genetic characteristics of a patient's tumor. Precision medicine minimizes the trial-and-error approach to cancer treatment, reducing the time and resources spent on unsuccessful therapies. Point-of-Care Testing The growing advancements in point-of-care testing have enabled rapid and accurate cancer diagnosis at the patient's bedside or in smaller healthcare facilities. These portable devices can detect cancer biomarkers quickly, reducing the time required for diagnosis and enabling immediate treatment decisions. Mobile Cancer Screening Units Awareness campaigns have not only educated the public but have also paved the way for improved access to cancer screening services. Mobile cancer screening units, diagnostic clinics, and specialized cancer centers have become more prevalent, ensuring that individuals can undergo necessary screenings conveniently and affordably. Telemedicine Telemedicine platforms allow patients to consult with oncologists and diagnostic specialists remotely, without the need for in-person appointments. In a fast-paced urban environment like many parts of India, where traffic congestion and time constraints are common, telemedicine enhances accessibility to cancer diagnostic consultations. Early Detection Technologies Cancer diagnostics, including screening tests like mammograms, Pap smears, colonoscopies, and blood tests for tumor markers, facilitate the early detection of cancer or precancerous conditions. Early detection allows for the identification of cancer at its initial stages, often before symptoms manifest. Drivers of Market Growth Increased Awareness The concerted efforts to raise awareness about cancer and promote early detection have had a profound impact on the India Cancer Diagnostics market. The shift in societal attitudes, coupled with increased accessibility to screening services and the development of advanced diagnostic tests, has positioned the market for substantial growth. Healthcare Investments The Indian government and private sector are investing heavily in cancer diagnostics. This investment is leading to the development of new cancer diagnostic tests and reagents and the expansion of cancer diagnostic facilities. These factors are expected to drive the growth of the market. Lifestyle Factors According to the National NCD Monitoring Survey (NNMS) conducted during 2017-2018, the prevalence of tobacco and alcohol use was 32.8%. More than one-third (41.3%) of adults were physically inactive, nearly all (98.4%) consumed less than 5 servings of fruits and/or vegetables per day, and the mean salt intake was 8 g/day. The rising burden of cancer in India presents a formidable challenge to public health, driven by these lifestyle factors. Demographic Changes The rising cancer incidence in India is driven by demographic changes, lifestyle factors, environmental influences, and awareness levels. This surge in cancer cases has not only posed significant challenges for the healthcare system but has also fueled the growth of the India Cancer Diagnostics market. Competitive Analysis
Major Players Several major companies are operating in the India Cancer Diagnostics Market, contributing to its growth and development. These companies include:
North India Market Leadership North India, particularly the National Capital Region (NCR) and major cities like Delhi, has historically had a more advanced healthcare infrastructure compared to other regions. The presence of top-tier hospitals, cancer centers, and diagnostic laboratories in these areas has contributed to the dominance of North India in the cancer diagnostics market.
South India Market Growth The South India segment is poised to be the fastest-growing market, offering lucrative growth opportunities for cancer diagnostics players during the forecast period. Factors such as substantial investments in healthcare infrastructure and the presence of premier healthcare institutions drive market growth in this region.
Benefits of the Research Report The research report on the India Cancer Diagnostics Market provides several benefits:
Challenges and Opportunities
Limited Healthcare Infrastructure One of the primary challenges hindering market growth is the limited healthcare infrastructure in many parts of India. The availability of specialized diagnostic facilities and trained personnel is often inadequate, particularly in rural and remote areas.
High Cost of Diagnostic Procedures The high cost of diagnostic procedures can be a barrier for many patients, limiting access to timely and accurate cancer diagnosis. Efforts to reduce costs and improve affordability are essential for expanding market reach.
Lack of Awareness and Stigma Despite growing awareness, there remains a significant lack of awareness about cancer and its symptoms among certain segments of the population. Additionally, social stigma associated with cancer can prevent individuals from seeking timely medical advice and undergoing necessary diagnostic tests.
Opportunities for Growth The India Cancer Diagnostics Market presents several opportunities for growth, driven by increased healthcare investments, technological advancements, and government initiatives. Efforts to improve healthcare infrastructure, reduce costs, and raise awareness about cancer can further enhance market growth. The India Cancer Diagnostics Market is poised for significant growth in the coming years, driven by rising cancer incidence, technological advancements, and increased healthcare investments. Efforts to raise awareness about cancer and promote early detection have had a profound impact on the market, positioning it for substantial growth. As the nation continues to address the health crisis posed by cancer, the diagnostic industry plays a pivotal role in early detection, accurate diagnosis, and ultimately improving patient outcomes. The research report provides valuable insights into market dynamics, competitive landscape, and growth opportunities, offering a comprehensive analysis of the India Cancer Diagnostics Market.
“The Advancements in Technology and increasing Public awareness campaigns and education are key drivers of the Cancer Diagnostics market. In recent years, the growing trend toward personalized medicine and targeted therapies fuels the demand for diagnostic tests that identify specific biomarkers and genetic mutations. Moreover, the growing consumer emphasis on preventative healthcare products has enhanced production and marketing efforts. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Cancer Diagnostics and supplements market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm. “India Cancer Diagnostics Market Segmented By Product (Instruments, Consumables, Services), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By Test-Type (Biopsy, Others), By End-User (Hospitals, Laboratories, Others), By Country, Competition, Forecast, Opportunities, 2019-2029F”, has evaluated the future growth potential of India Cancer Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Cancer Diagnostics Market.
Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=18914 Customers can also request for 10% free customization on this report.
Recently Published Report –
Vietnam Vitamin & Mineral Premixes Market Vietnam Industrial Enzymes Market Contact US - Techsci Research LLC 420 Lexington Avenue, Suite 300, New York, United States- 10170 Tel: +13322586602 Like it? Share it! More by this author |